The below article is a powerful Q&A approach to educating the public about the harms of marijuana while proving that popular opinion/movements are quite deceptive and deadly. There is one error, however, in this account: Marinol and Cesamet are FDA approved synthetic THC. The article states that: “Physicians can write prescriptions for three FDA approved cannabidiol-based (CBD) pure drugs with individual indications for nausea and vomiting of chemotherapy, or childhood seizures or weight loss/ poor appetite (Marinol®, Epidolex®, and Cesamet®).” Correcting this misstatement only strengthens our case. Any medical help from THC is known and vetted, and has been prescribed by doctors for specific conditions for years.
Addiction Professional magazine
August 18, 2016 by Tom Valentino, Senior Editor As presented at the National Conference on Addiction Disorders in Denver, August 18, 2016 by Jennifer Golick, LMFT, PhD (clinical director at Muir Wood Adolescent and Family Services) stated “cannabis use does, in fact, pose serious, long-term health risks for adolescents.”
Psychiatry & Behavioral Health Learning Network
Newly published study (American Academy of Addiction Psychiatry): Long lasting effects of chronic heavy cannabis abuse
Joannis N. Nestoros MD, PhD1, Elena Vakonaki PhD2, Manolis N. Tzatzarakis PhD2, Athanasios Alegakis PhD2, Markos D. Skondras MD, PhD3 and Aristidis M. Tsatsakis PhD, DSc2,* Version of Record online: 17 MAR 2017 DOI: 10.1111/ajad.12529 Copyright © 2017 American Academy of Addiction Psychiatry. Conclusions: “The existence of hallucinations, delusions, and organic brain dysfunction in heavy cannabis users seems to be associated with cannabinoid levels in hair. The continuation of persistent symptoms 3 months after the discontinuation of cannabis abuse, was a remarkable finding.” Scientific Significance: “We provide evidence that chronic and heavy cannabis abuse results in long-lasting brain dysfunction in all users and in long-lasting schizophrenia-like psychotic symptoms in more than half of all users. These findings suggest a reevaluation of the current classification of cannabis as a “soft narcotic” which erroneously, therefore, is typically considered harmless.” (Am J Addict 2017;XX:1–8)
Background and Objectives The purpose of this study was to evaluate the extent of short‐term memory impairment and schizophrenia‐like symptoms in heavy and systematic cannabis users and the associat…
Cannabis Killed My Son, Don’t Let it Do the Same to You
A drug-induced psychosis led James to refuse chemotherapy treatment. His death was recorded as being partly caused by schizophrenia, which his family believe was triggered by cannabis addiction.
Janie Hamilton, from North Dorset, lost her 36-year-old son to testicular cancer A drug-induced psychosis led James to refuse chemotherapy treatment His death was recorded as being partly caused by schizophrenia, which his family believe was triggered by cannabis addiction A retired teacher whose son’s death was caused by mental illness brought on by cannabis is touring schools to warn children about the drug.
This is a 50 minute presentation by Libby Stuyt, MD (addiction psychiatrist in CO) delivered to the Oregon Law & Mental Health Conference in Portland on 6/16/17.
Libby Stuyt, MD spoke at the Oregon Health Forum with Drs. Esther Choo of OHSU and Katrina Hedberg who is the State Epidemiologist and State Health Officer at the Oregon Public Health Division, and at the Oregon Law & Mental Health Conference in June 2017 on the unintended consequences of marijuana legalization.
Think it’s harmless? Now nine in ten teens at drug clinics are being treated for marijuana use (United Kingdom)
Cannabis is responsible for 91% of drug addiction cases involving teenagers Skunk – high-potency herbal cannabis – causing more people to seek treatment Backs up research that skunk is having detrimental impact on mental health Cannabis is responsible for 91 per cent of cases where teenagers end up being treated for drug addiction, shocking new figures reveal.
In 2016, just over one-quarter of all treatment presentations in the UK were for primary cannabis use (see accompanying table 3.1). The pattern is starkly different for young people (under the age of 18) in drug treatment, with 91% citing cannabis as the primary drug bringing them into treatment (Public Health England, 2017).
United Kingdom Drug Situation, 2017
Click here to see the 2017 UK Report on Drug Situation.
One UK Family’s Horror Story
Janie Hamilton’s son James died aged just 36 when he refused to have chemotherapy for testicular cancer after years battling mental illness. His death was recorded as being partly caused by schizophrenia, which his family believe was triggered by his addiction to cannabis from the age of 14.